Sandra Boenisch Biography and Net Worth

Treasurer of Anavex Life Sciences

Sandra Boenisch serves as Principal Financial Officer, Treasurer of the Company. Ms. Boenisch is a Chartered Professional Accountant (CPA, CGA) with 14 years of accounting, audit, and financial reporting experience in a variety of industries, both in the United States and Canada. Ms. Boenisch has been an independent consultant, providing financial reporting services to a range of public companies in the United States and Canada since January 2012. From 2008 until 2012, Ms. Boenisch was employed at BDO Canada LLP (Vancouver, BC) where she was hired as a Senior Accountant and was later promoted to Manager, Audit Assurance. Ms. Boenisch specialized in managing assurance engagements for public companies in the United States and Canada. Prior to that, Ms. Boenisch worked for another public accounting firm from 2001 to 2008. As an independent consultant, Ms. Boenisch has acquired considerable experience in finance, governance, and regulatory compliance. She holds a BComm from Laurentian University.

What is Sandra Boenisch's net worth?: The estimated net worth of Sandra Boenisch is at least $327,827.11 as of June 29th, 2021. Ms. Boenisch owns 47,963 shares of Anavex Life Sciences stock worth more than $327,827 as of November 2nd. This net worth approximation does not reflect any other assets that Ms. Boenisch may own. Additionally, Ms. Boenisch receives an annual salary of $194,360.00 as Treasurer at Anavex Life Sciences. Learn More about Sandra Boenisch's net worth.
How old is Sandra Boenisch?: Ms. Boenisch is currently 43 years old. There are 2 older executives and no younger executives at Anavex Life Sciences. The oldest executive at Anavex Life Sciences is Dr. Christopher U. Missling M.B.A., M.S., Ph.D., President, CEO, Secretary & Director, who is 58 years old. Learn More on Sandra Boenisch's age.
What is Sandra Boenisch's salary?: As the Treasurer of Anavex Life Sciences Corp., Ms. Boenisch earns $194,360.00 per year. The highest earning executive at Anavex Life Sciences is Dr. Christopher U. Missling M.B.A., M.S., Ph.D., President, CEO, Secretary & Director, who commands a salary of $828,250.00 per year. Learn More on Sandra Boenisch's salary.
How do I contact Sandra Boenisch?: The corporate mailing address for Ms. Boenisch and other Anavex Life Sciences executives is 51 W 52ND STREET 7TH FLOOR, NEW YORK NY, 10019. Anavex Life Sciences can also be reached via phone at (844) 689-3939 and via email at [email protected]. Learn More on Sandra Boenisch's contact information.
Has Sandra Boenisch been buying or selling shares of Anavex Life Sciences?: Sandra Boenisch has not been actively trading shares of Anavex Life Sciences during the last ninety days. Most recently, Sandra Boenisch sold 166,696 shares of the business's stock in a transaction on Tuesday, June 29th. The shares were sold at an average price of $26.53, for a transaction totalling $4,422,444.88. Following the completion of the sale, the treasurer now directly owns 47,963 shares of the company's stock, valued at $1,272,458.39. Learn More on Sandra Boenisch's trading history.
Who are Anavex Life Sciences' active insiders?: Anavex Life Sciences' insider roster includes Sandra Boenisch (Treasurer), Peter Donhauser (Director), Elliot Favus (Director), and Elliot Favus (Director). Learn More on Anavex Life Sciences' active insiders.
Are insiders buying or selling shares of Anavex Life Sciences?: In the last twelve months, Anavex Life Sciences insiders bought shares 2 times. They purchased a total of 7,835 shares worth more than $32,919.40. In the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 73,380 shares worth more than $374,971.80. The most recent insider tranaction occured on June, 14th when Director Peter D.O. Donhauser bought 2,835 shares worth more than $10,319.40. Insiders at Anavex Life Sciences own 11.0% of the company. Learn More about insider trades at Anavex Life Sciences.
Information on this page was last updated on 6/14/2024.

Sandra Boenisch Insider Trading History at Anavex Life Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/29/2021	Sell	166,696	$26.53	$4,422,444.88	47,963

Sandra Boenisch Buying and Selling Activity at Anavex Life Sciences

Anavex Life Sciences Company Overview

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Today's Range

Now: $6.84

$6.50

$7.07

50 Day Range

MA: $5.58

$5.01

$6.84

2 Week Range

Now: $6.84

$3.25

$10.45

Volume

2,000,680 shs

Average Volume

1,159,568 shs

Market Capitalization

$579.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Sandra Boenisch Biography and Net Worth

What is Sandra Boenisch's net worth?

How old is Sandra Boenisch?

What is Sandra Boenisch's salary?

How do I contact Sandra Boenisch?

Has Sandra Boenisch been buying or selling shares of Anavex Life Sciences?

Who are Anavex Life Sciences' active insiders?

Are insiders buying or selling shares of Anavex Life Sciences?